Industry: Life Sciences
Services: Project Management, Consulting
Duration: 9 months
Estimated Project Value: $25,000,000
CHALLENGE: The client, a research and development life science company, sought to acquire a revenue-generating product to assist in funding research and development endeavors. The client engaged ACM to establish a project execution plan for the Asset Purchase Agreement and to execute critical path method (CPM) project management through a Transition Services Agreement (TSA).
SOLUTION: To meet the requirements and deadlines of the TSA, ACM:
- Implemented a CPM schedule to facilitate the entire business integration process, human resources, facility lease, asset transfer, operations management, drug product, license ownership, information technology (IT), and financial operations.
- Coordinated planning meetings, cross functional integration visioning and process meetings and established accountability to stakeholders by providing weekly schedule updates to the various stakeholders, integrating feedback, and reporting on progress.
- Coordinated and led weekly stakeholder meetings for licensing, finance, information technology, and software applications, as well as other team meetings for various key work streams.
- Compiled and organized information from the various stakeholders in order to provide updates to the CPM master schedule.
Asset transition from European Union ownership to U.S. ownership was executed in a timely manner without issue. A large European pharmaceutical company agreed to sell off U.S. lab operations in Massachusetts as well as a Cellular Therapy and Regenerative Medicine product.